Pulmo-oncology is an emerging discipline at the intersection of pulmonary medicine and oncology, playing a critical role in the clinical care of patients with cancer. The respiratory system is often impacted by direct cancer involvement and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

Now in its fourth year, this symposium brings together globally recognized experts from multiple disciplines to present the latest advances in cancer therapies and best practices in the evaluation and management of lung disease. Through state-of-the-art presentations and interdisciplinary, case-based discussions, this symposium will explore key topics related to the care of cancer patients with pulmonary comorbidities and complications arising from cancer or its treatments.

Key Topics Include 

• State-of-the-art updates in lung cancer treatment
• Clinical strategies for management of drug toxicities, symptoms, and co-existing pulmonary conditions
• Emerging AI screening and continuous monitoring technologies as well as social media modalities into clinical management for cancer patients at risk of pulmonary complications

Complex cases will be integrated throughout the program, with dedicated time for interactive, multidisciplinary panel discussions to foster meaningful engagement between participants and faculty.

This symposium is intended for healthcare professionals in pulmonology, hematology/oncology, and related disciplines involved in the care of patients with cancer or those with a special interest in this area.